Dr. Schmaier on Managing Thrombosis in Hematologic Malignancies

Alvin H. Schmaier, MD
Published: Friday, Mar 27, 2020



Alvin H. Schmaier, MD, professor in the Department of Medicine and the Department of Pathology at Case Western Reserve University School of Medicine, discusses managing thrombosis in patients with hematologic malignancies.

Cancer-associated thrombosis (CAT) is a known cause of morbidity in patients with hematologic malignancies. However, evidence-based data regarding CAT has led to the development of novel prophylactic and therapeutic treatments for patients, says Schmaier.

This data has informed CAT prevention and management, as well as secondary management for patients who have already received CAT treatment, explains Schmaier.

Novel anticoagulant agents have expanded the treatment paradigm and allowed for better adjunctive treatment of patients with cancer, concludes Schmaier.
SELECTED
LANGUAGE


Alvin H. Schmaier, MD, professor in the Department of Medicine and the Department of Pathology at Case Western Reserve University School of Medicine, discusses managing thrombosis in patients with hematologic malignancies.

Cancer-associated thrombosis (CAT) is a known cause of morbidity in patients with hematologic malignancies. However, evidence-based data regarding CAT has led to the development of novel prophylactic and therapeutic treatments for patients, says Schmaier.

This data has informed CAT prevention and management, as well as secondary management for patients who have already received CAT treatment, explains Schmaier.

Novel anticoagulant agents have expanded the treatment paradigm and allowed for better adjunctive treatment of patients with cancer, concludes Schmaier.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x